Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

May 25, 2025 12:00 PM BST | By Cision
 Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025
Image source: Kalkine Media

SHENZHEN, China, May 25, 2025 /PRNewswire/ -- Mindray (SZSE: 300760), a leading global developer of healthcare technologies, launched its BeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon. Powered by a robust new hardware platform, this advanced system provides industry-first innovations in ultrasound-integrated hemodynamic assessment and cable-lite patient monitoring workflow, redefining the bedside monitor as a dynamic hub of precision medicine.

Mindray BeneVision V Series with Ultrasound Integration
Mindray BeneVision V Series with Ultrasound Integration

Ralph Zhao, General Manager of Sales & Marketing, Mindray Patient Monitoring & Life Support, shared: "Our new patient monitoring system future-proofs standards of care to help clinicians see patient status as a whole, making better use of multi-modal data from different devices for actionable insights."

The increasing utilisation of point-of-care ultrasound in the ICU has transformed patient assessment and management. The new BeneVision V Series connects with ultrasound systems, including the TE Air handheld ultrasound, to systemically integrate imaging data for more insightful decision-making support. This bedside innovation enables clinicians to get clearer ultrasound images on screen, so they can visualise, analyse and document ultrasound findings both in real-time and through historical trends. The upgraded HemoSight™ tool aligns ultrasound-derived parameters with vital signs for synchronised evaluation, generating a more comprehensive hemodynamic profile for timely decision-making.

The MRV PodTM is another innovative breakthrough that enhances vital signs monitoring in critical care, improving patient mobility and optimising clinical workflows. This industry-first, full-parameter, cable-lite solution transmits vital signs data wirelessly to the BeneVision V Series monitor. This frees patients from bedside cables, allowing unimpeded mobility while streamlining workflow and cable management for nurses. Combined with the widely recognised BeneVision N1 transport monitor, the new solution supports continuous monitoring during patient transport for efficient, integrated care.

In addition, the top-of-the-line VMAX features a 4K UHD capacitive screen in an ultra-slim design. Its 360-degree visible alarm lights ensure critical alerts can be seen from any angle, minimising missed alarms and enhancing safety. The responsive touchscreen interface allows for smooth navigation and easy customisation. Clinicians can personalize displays with a simple drag-and-drop, and adjust waveform amplitude using pinch-to-zoom gestures.

"Through our continued collaborations with hospitals and academic institutions, we strive to empower clinicians to provide more personalised and focused care, enhancing patient attention. We anticipate further collaborative outcomes that will lead to improved data analysis and applications for more efficient workflows," added Zhao.

For more about Mindray, please visit https://www.mindray.com


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AI on the Rise: A Look at Top AI Companies and Their Stocks

Send OTP Resend OTP in 30s
Verify OTP

Sponsored Articles


Investing Ideas

Previous Next